These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14119988)

  • 1. HEPATOLENTICULAR DEGENERATION; CLINICAL AND BIOCHEMICAL STUDY OF THREE CASES.
    CANELAS HM; ESCALANTE OD; DE JORGE FB; ROCHA-QINTAO EC
    Arq Neuropsiquiatr; 1963 Dec; 21():229-50. PubMed ID: 14119988
    [No Abstract]   [Full Text] [Related]  

  • 2. [HEPATOLENTICULAR DEGENERATION, ACUTE ANEMIA AND HEPATIC INSUFFICIENCY LONG PRECEDING THE NEUROLOGICAL SYMPTOMS].
    TURPIN R; CAILLE B; LAFOURCADE J; JEROME H; BOUTELIER D; DEFRANOUX A
    Ann Pediatr (Paris); 1963; 10():277-83. PubMed ID: 14126013
    [No Abstract]   [Full Text] [Related]  

  • 3. HEPATOLENTICULAR DEGENERATION: OBSERVATIONS ON A CASE TREATED WITH D-PENICILLAMINE.
    HERRING VG; KLATSKIN G; BRANDT IK
    J Pediatr; 1963 Oct; 63():550-60. PubMed ID: 14074413
    [No Abstract]   [Full Text] [Related]  

  • 4. HEPATO-LENTICULAR DEGENERATION (WILSON'S DISEASE) TREATED BY PENICILLAMINE.
    RICHMOND J; ROSENOER VM; TOMPSETT SL; DRAPER I; SIMPSON JA
    Brain; 1964 Dec; 87():619-38. PubMed ID: 14236007
    [No Abstract]   [Full Text] [Related]  

  • 5. COPPER METABOLISM IN NORMAL SUBJECTS.
    Cartwright GE; Wintrobe MM
    Am J Clin Nutr; 1964 Apr; 14():224-32. PubMed ID: 14142382
    [No Abstract]   [Full Text] [Related]  

  • 6. [HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION].
    AKSOY M; BIYAL F; SECER F; CAKIRGOEZ C; CETINGIL AI
    Tip Fak Mecm; 1964; 27():37-55. PubMed ID: 14140395
    [No Abstract]   [Full Text] [Related]  

  • 7. FILTERABLE AND NON-FILTERABLE SERUM COPPER. (2). STUDIES WITH 64CU.
    OSBORN SB; WALSHE JM
    Clin Sci; 1964 Apr; 26():213-7. PubMed ID: 14161054
    [No Abstract]   [Full Text] [Related]  

  • 8. ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE.
    WALSHE JM
    Clin Sci; 1964 Jun; 26():461-9. PubMed ID: 14191274
    [No Abstract]   [Full Text] [Related]  

  • 9. [CERULOPLASMIN CONTENT IN PATIENTS WITH HEPATOCEREBRAL DYSTROPHY AND IN THEIR HEALTHY RELATIVES].
    MITTELSHTEDT AA; BAUMAN LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():819-21. PubMed ID: 14235907
    [No Abstract]   [Full Text] [Related]  

  • 10. CLINICAL AND PATHOLOGICAL CHARACTERISTICS IN WILSON'S DISEASE IN CASES UNDER TEN YEARS OF AGE.
    ARIMA M; KOMIYA K; KAMOSHITA S; MUKAI N
    Paediatr Univ Tokyo; 1963 Dec; 9():17-22. PubMed ID: 14157269
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of clinical and biochemical spectrum of Wilson disease patients.
    Mansoor S; Naveed AK; Majeed A
    Indian J Pathol Microbiol; 2012; 55(3):365-9. PubMed ID: 23032833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHROMATOGRAPHIC AND MAGNETIC STUDIES ON HUMAN CERULOPLASMIN.
    BROMAN L
    Acta Soc Med Ups; 1964; 69():SUPPL 7:1-85. PubMed ID: 14229509
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 14. Copper metabolism after living donor liver transplantation for hepatic failure of Wilson's disease from a gene mutated donor.
    Kobayashi S; Ochiai T; Hori S; Suzuki T; Shimizu T; Gunji Y; Shimada H; Yamamoto S; Ogawa A; Kohno Y; Sunaga M; Shimazu M; Tanaka K
    Hepatogastroenterology; 2001; 48(41):1259-61. PubMed ID: 11677941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BIOCHEMICAL ASPECTS OF COPPER AND AROMATIC AMINES IN RELATION TO THE EXTRAPYRAMIDAL SYSTEM.
    WALAAS E; WALAAS O
    Acta Neurol Scand Suppl; 1963; 39(4):SUPPL4:84-94. PubMed ID: 14057524
    [No Abstract]   [Full Text] [Related]  

  • 16. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

  • 18. DISTURBANCES OF COPPER AND AMINO ACID METABOLISM IN CLINICALLY HEALTHY RELATIVES OF PATIENTS WITH HEPATOLENTICULAR DEGENERATION.
    PATRUNOVA VP
    Fed Proc Transl Suppl; 1964; 23():340-2. PubMed ID: 14145670
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease.
    CARTWRIGHT GE; MARKOWITZ H; SHIELDS GS; WINTROBE MM
    Am J Med; 1960 Apr; 28():555-63. PubMed ID: 13808058
    [No Abstract]   [Full Text] [Related]  

  • 20. FAMILIAL HEPATIC COPPER STORAGE DISEASE: A VARIANT OF WILSON'S DISEASE.
    FISHER MM; SHERLOCK S
    Arch Dis Child; 1964 Feb; 39(203):14-7. PubMed ID: 14160082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.